Literature DB >> 12807763

Alterations in signal transduction pathways implicated in tumour progression during multistage mouse skin carcinogenesis.

Vassilis Zoumpourlis1, Sylvia Solakidi, Alexandra Papathoma, Dimitra Papaevangeliou.   

Abstract

The multistage mouse skin carcinogenesis model, although an artificial one, is an ideal system to study the timing of qualitative and quantitative alterations which take place during the different stages of chemical carcinogenesis, allowing analysis of the events that lead to the transition from the stage of initiation to the stage of promotion and finally to the progression of carcinogenesis. In this review we focus on the role of the H-ras gene and its target molecules during mouse skin carcinogenesis. Besides H-ras, which is a critical target of chemical carcinogens, we report alterations in oncosuppressor genes. Finally, we examine the potential suppression of metastatic dynamics of spindle cells after biological or chemical inhibition of the signalling cascades involved in mouse skin carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807763     DOI: 10.1093/carcin/bgg067

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  20 in total

1.  Variants in an Hdac9 intronic enhancer plasmid impact Twist1 expression in vitro.

Authors:  Tyler E Siekmann; Madelyn M Gerber; Amanda Ewart Toland
Journal:  Mamm Genome       Date:  2015-12-31       Impact factor: 2.957

2.  Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis.

Authors:  Haris G Vikis; Andrew E Gelman; Andrew Franklin; Lauren Stein; Amy Rymaszewski; Jihong Zhu; Pengyuan Liu; Jay W Tichelaar; Alexander S Krupnick; Ming You
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

3.  Soluble and insoluble nickel compounds exert a differential inhibitory effect on cell growth through IKKalpha-dependent cyclin D1 down-regulation.

Authors:  Weiming Ouyang; Dongyun Zhang; Jingxia Li; Udit N Verma; Max Costa; Chuanshu Huang
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 4.  Pathogenesis of pancreatic cancer: lessons from animal models.

Authors:  L Charles Murtaugh
Journal:  Toxicol Pathol       Date:  2013-10-31       Impact factor: 1.902

5.  Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model.

Authors:  Shannon L Nowotarski; Lisa M Shantz
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

6.  Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment.

Authors:  Shadmehr Demehri; Ahu Turkoz; Raphael Kopan
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743

7.  A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1.

Authors:  Haidan Liu; Joonsung Hwang; Wei Li; Tae Woong Choi; Kangdong Liu; Zunnan Huang; Jae-Hyuk Jang; N R Thimmegowda; Ki Won Lee; In-Ja Ryoo; Jong-Seog Ahn; Ann M Bode; Xinmin Zhou; Yifeng Yang; Raymond L Erikson; Bo-Yeon Kim; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2013-10-29

8.  Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma.

Authors:  Amit Mittal; Mike Wang; Aurobind Vidyarthi; Diana Yanez; Gabriela Pizzurro; Durga Thakral; Erin Tracy; Oscar R Colegio
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.996

9.  No evidence for induction of key components of the Notch signaling pathway (Notch-1, Jagged-1) by treatment with UV-B, 1,25(OH)(2)D(3), and/or epigenetic drugs (TSA, 5-Aza) in human keratinocytes in vitro.

Authors:  Sandra Reichrath; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2012-01-01

10.  Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion.

Authors:  Satish B Cheepala; Weihong Yin; Zanobia Syed; Jennifer N Gill; Alaina McMillian; Heather E Kleiner; Mark Lynch; Rasiah Loganantharaj; Marjan Trutschl; Urska Cvek; John L Clifford
Journal:  Mol Cancer       Date:  2009-05-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.